Change search
ReferencesLink to record
Permanent link

Direct link
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Umeå University, Faculty of Medicine, Public Health and Clinical Medicine, Medicine.
Show others and affiliations
2004 (English)In: Circulation, ISSN 1524-4539, Vol. 110, no 11, 1456-62 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 110, no 11, 1456-62 p.
Keyword [en]
Adrenergic beta-Antagonists/*therapeutic use, Aged, Aged; 80 and over, Angiotensin II Type 1 Receptor Blockers/*therapeutic use, Antihypertensive Agents/therapeutic use, Atenolol/*therapeutic use, Blood Pressure/drug effects, Double-Blind Method, Female, Follow-Up Studies, Heart Rate/drug effects, Heart Ventricles/drug effects/pathology/ultrasonography, Humans, Hypertension/*complications/drug therapy, Hypertrophy; Left Ventricular/*drug therapy/etiology/ultrasonography, Losartan/*therapeutic use, Male, Middle Aged, Organ Size, Prospective Studies, Treatment Outcome
URN: urn:nbn:se:umu:diva-12922DOI: doi:10.1161PubMedID: 15326072OAI: diva2:152593
Available from: 2007-04-24 Created: 2007-04-24 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Boman, Kurt
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 20 hits
ReferencesLink to record
Permanent link

Direct link